Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famciclovir pediatric formulation in children with herpes simplex infection
2015-004441-17Phase 3
- Sponsor
- Novartis
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of famciclovir in herpes simplex (HSV), sponsored by Novartis. Primary endpoints: Single-dose pharmacokinetics of famciclovir and Safety and tolerability of famciclovir (single and multiple dose).
02
Drugs
famciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on 2015-004441-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004441-17.